Marshall Wace’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-271,736
Closed -$3.94M 2975
2025
Q1
$3.94M Buy
+271,736
New +$3.86M 0.01% 1176
2024
Q4
Sell
-34,300
Closed -$398K 2837
2024
Q3
$398K Sell
34,300
-99,891
-74% -$942K ﹤0.01% 2003
2024
Q2
$1.01M Buy
134,191
+83,082
+163% +$687K ﹤0.01% 1687
2024
Q1
$513K Buy
+51,109
New +$476K ﹤0.01% 1911
2023
Q2
Sell
-48,917
Closed -$729K 2765
2023
Q1
$729K Buy
48,917
+14,172
+41% +$215K ﹤0.01% 1950
2022
Q4
$516K Sell
34,745
-208,170
-86% -$3.4M ﹤0.01% 2356
2022
Q3
$4.01M Buy
+242,915
New +$4.89M 0.01% 1539
2020
Q3
Sell
-12,473
Closed -$213K 1788
2020
Q2
$213K Buy
12,473
+1,324
+12% +$19.6K ﹤0.01% 1402
2020
Q1
$130K Sell
11,149
-31,001
-74% -$639K ﹤0.01% 1274
2019
Q4
$1.17M Sell
42,150
-3,220
-7% -$80.7K 0.01% 948
2019
Q3
$1.03M Buy
+45,370
New +$1.03M 0.01% 942
2019
Q1
Sell
-56
Closed -$2K 1926
2018
Q4
$2K Sell
56
-75,610
-100% -$3.04M ﹤0.01% 1552
2018
Q3
$3.53M Buy
+75,666
New +$3.47M 0.03% 542
2016
Q1
Sell
-26,753
Closed -$1.92M 1127
2015
Q4
$1.92M Buy
+26,753
New +$1.98M 0.02% 574
2015
Q3
Sell
-7,600
Closed -$563K 1008
2015
Q2
$563K Sell
7,600
-500
-6% -$36K 0.01% 691
2015
Q1
$587K Buy
8,100
+4,999
+161% +$348K 0.01% 654
2014
Q4
$205K Hold
3,101
﹤0.01% 747
2014
Q3
$170K Buy
+3,101
New +$176K ﹤0.01% 801

Other funds holding MD

Marshall Wace's MD Position: Q2 2025 in Review

Marshall Wace sold out of Pediatrix Medical (MD) in Q2 2025, closing a stake of 271,736 shares — an estimated $3.94M sold.

Marshall Wace first reported a position in MD in Q3 2014 and held it in 18 quarters. The position peaked at $4.01M in Q3 2022. 264 funds tracked by Wall St. Rank hold MD as of Q2 2025.

  • Marshall Wace reported no remaining Pediatrix Medical position as of Q2 2025 after selling out during the quarter.
  • Marshall Wace sold 271,736 Pediatrix Medical shares in Q2 2025, an estimated $3.94M.
  • Marshall Wace first reported a position in Pediatrix Medical in Q3 2014 and held it in 18 quarters.
  • Marshall Wace's Pediatrix Medical position peaked at $4.01M in Q3 2022.
  • 264 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2025.

Based on Marshall Wace's 13F filing for Q2 2025, filed 13 Aug 2025.